EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of an Indirect ELISA Based on the PEDV S Protein and Evaluation of Its Correlation With Neutralizing Antibody and Immune Protection

Guangming Ma, Guangli Hu, Guangcai Ren, Wang Ma, Shuqiong Zhang iD, Hanqin Shen iD, Yuanjia Liu iD, Bin Li

Transboundary and Emerging Diseases · 2025-01 · 2025 (1)

DOI: 10.1155/tbed/6185969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 28.12.2025. Verfasst von Guangming Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang, 524088, China, gdou.edu.cn. Hauptthemen laut MEDLINE: Enzyme-Linked Immunosorbent Assay, Coronavirus Infections, Spike Glycoprotein, Coronavirus, Antibodies, Neutralizing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Ocean University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine epidemic diarrhea virus (PEDV) is an enteric coronavirus that infects pigs of all ages. Notably, neonatal piglets (≤7 days old) in naïve herds can experience case fatality rates approaching 100%, with hallmark clinical signs of vomiting, diarrhea, and dehydration, thereby representing a major threat to swine herd health. Serum PEDV‐specific IgG serves as a key serological marker of vaccine‐induced herd immunity. Accordingly, we developed an indirect ELISA (iELISA) using Chinese hamster ovary (CHO) cell‐expressed recombinant PEDV spike (S) protein as the coating antigen. Checkerboard titration identified the optimal antigen‐coating concentration and serum dilution as 1 μg/mL and 1:300, respectively. Based on sample‐to‐positive (S/P) ratios from 50 PEDV‐negative sera, the diagnostic cutoff was set at 0.796, corresponding to the mean plus 3 standard deviation (SD) of the negative control group ( n = 50). The intra‐ and interassay coefficients of variation (CVs) were both

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enzyme-Linked Immunosorbent AssayCoronavirus InfectionsSpike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralAnimalsSwinePorcine epidemic diarrhea virusAntigens, ViralVaccinationNeutralization Tests

Substanzen

Spike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralAntigens, Viral

Autor:innen und Institutionen

  • College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang, 524088, China, gdou.edu.cn.
  • Key Laboratory of Manufacture Technology of Veterinary Bioproducts, Ministry of Agriculture and Rural Affairs, Zhaoqing Dahuanong Biology Medicine Co., Ltd, Zhaoqing, Guangdong, 526200, China, agri.gov.cn.
  • State Key Laboratory of Biocontrol, Guangzhou Higher Education Mega Center, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510000, China, sysu.edu.cn.
  • Canton Biologics Co. Ltd, Guangzhou, 510700, China.
  • Neimenggu Chia Tai Food Co. Ltd, Huhehaote, 010000, China.

ORCID-Profile: Shuqiong Zhang, Hanqin Shen, Yuanjia Liu

Förderung

  • Guangdong Ocean University

Zitieren

APA

Ma, G., Hu, G., Ren, G., Ma, W., Zhang, S., Shen, H., Liu, Y., & Li, B. (2025). Development of an Indirect ELISA Based on the PEDV S Protein and Evaluation of Its Correlation With Neutralizing Antibody and Immune Protection. Transboundary and Emerging Diseases, 2025(1). https://doi.org/10.1155/tbed/6185969

Vancouver

Ma G, Hu G, Ren G, Ma W, Zhang S, Shen H, et al. Development of an Indirect ELISA Based on the PEDV S Protein and Evaluation of Its Correlation With Neutralizing Antibody and Immune Protection. Transboundary and Emerging Diseases. 2025;2025(1). doi:10.1155/tbed/6185969

BibTeX
@article{Ma2025,
  author = {Ma, Guangming and Hu, Guangli and Ren, Guangcai and Ma, Wang and Zhang, Shuqiong and Shen, Hanqin and Liu, Yuanjia and Li, Bin},
  title = {Development of an Indirect ELISA Based on the PEDV S Protein and Evaluation of Its Correlation With Neutralizing Antibody and Immune Protection},
  journal = {Transboundary and Emerging Diseases},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/tbed/6185969}
}
Kostenlos starten →